Nexalin Technology (NXL) Gross Margin Growth (1y) (2022 - 2026)
Nexalin Technology (NXL) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | -65.00 |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 610.00 |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | -359.00 |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | 9.00 |
| 10 | Nexalin Technology | 9.43 Mn | 6.72 Mn | 13,133.00 | 2,090.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,090.00 |
| Dec 31, 2025 | 1,535.00 |
| Sep 30, 2025 | 1,348.00 |
| Jun 30, 2025 | -535.00 |
| Mar 31, 2025 | -2,142.00 |
| Dec 31, 2024 | -211.00 |
| Sep 30, 2024 | -1,875.00 |
| Jun 30, 2024 | -62.00 |
| Mar 31, 2024 | 1,163.00 |
| Dec 31, 2023 | -760.00 |
| Sep 30, 2023 | 1,787.00 |
| Jun 30, 2023 | 332.00 |
| Mar 31, 2023 | -903.00 |
| Dec 31, 2022 | -2,206.00 |
| Sep 30, 2022 | -1,772.00 |